GE HealthCare Technologies Inc. (LON:0ADL)
London
· Delayed Price · Currency is GBP · Price in USD 71.74
0.00 (0.00%)
At close: Jun 25, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Product | 13.08B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Product Growth | 0.81% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Service | 6.60B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Service Growth | 3.07% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Patient Care Solutions (PCS) | 3.13B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Patient Care Solutions (PCS) Growth | 0.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceutical Diagnostics (PDx) | 2.51B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceutical Diagnostics (PDx) Growth | 8.27% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 14.04B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 204.44% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Imaging Revenue (Post-Q2 2024) | 8.86B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Imaging Revenue (Post-Q2 2024) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Advanced Visualization Solutions (AVS) | 5.13B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Advanced Visualization Solutions (AVS) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Imaging | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Imaging Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Ultrasound | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Ultrasound Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 14.04B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 204.44% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Other | 1.89B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 391.12% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Patient Care Solutions (PCS) Segment EBIT | 347.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Patient Care Solutions (PCS) Segment EBIT Growth | -11.55% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceutical Diagnostics (PDx) Segment EBIT | 783.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceutical Diagnostics (PDx) Segment EBIT Growth | 26.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Segment EBIT | 2.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Segment EBIT Growth | -37.50% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 1.89B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 391.12% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Imaging EBIT (Post-Q2 2024) | 962.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Imaging EBIT (Post-Q2 2024) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Advanced Visualization Solutions (AVS) EBIT | 1.12B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Advanced Visualization Solutions (AVS) EBIT Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Imaging Segment EBIT | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Imaging Segment EBIT Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Ultrasound Segment EBIT | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Ultrasound Segment EBIT Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
USCAN | 8.98B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
USCAN Growth | 6.59% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EMEA | 5.05B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EMEA Growth | -0.26% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China | 2.36B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China Growth | -13.06% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of World | 3.28B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of World Growth | 3.45% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Products Remaining Performance Obligations (RPO) | 4.76B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Products Remaining Performance Obligations (RPO) Growth | -3.02% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Services Remaining Performance Obligations (RPO) | 9.74B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Services Remaining Performance Obligations (RPO) Growth | 7.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|